Inositol-1,4,5-trisphosphate Receptor Regulates Hepatic Gluconeogenesis in Fasting and Diabetes

Overview

Journal Nature

Specialty Science

Date 2012 Apr 13

PMID 22495310

Citations 111

Authors

Yiguo Wang

Gang Li

Jason Goode

Jose C Paz

Kunfu Ouyang

Robert Screaton

Wolfgang H Fischer

Ju Chen

Ira Tabas

Marc Montminy

Affiliations

Soon will be listed here.

Abstract

In the fasted state, increases in circulating glucagon promote hepatic glucose production through induction of the gluconeogenic program. Triggering of the cyclic AMP pathway increases gluconeogenic gene expression via the de-phosphorylation of the CREB co-activator CRTC2 (ref. 1). Glucagon promotes CRTC2 dephosphorylation in part through the protein kinase A (PKA)-mediated inhibition of the CRTC2 kinase SIK2. A number of Ser/Thr phosphatases seem to be capable of dephosphorylating CRTC2 (refs 2, 3), but the mechanisms by which hormonal cues regulate these enzymes remain unclear. Here we show in mice that glucagon stimulates CRTC2 dephosphorylation in hepatocytes by mobilizing intracellular calcium stores and activating the calcium/calmodulin-dependent Ser/Thr-phosphatase calcineurin (also known as PP3CA). Glucagon increased cytosolic calcium concentration through the PKA-mediated phosphorylation of inositol-1,4,5-trisphosphate receptors (InsP(3)Rs), which associate with CRTC2. After their activation, InsP(3)Rs enhanced gluconeogenic gene expression by promoting the calcineurin-mediated dephosphorylation of CRTC2. During feeding, increases in insulin signalling reduced CRTC2 activity via the AKT-mediated inactivation of InsP(3)Rs. InsP(3)R activity was increased in diabetes, leading to upregulation of the gluconeogenic program. As hepatic downregulation of InsP(3)Rs and calcineurin improved circulating glucose levels in insulin resistance, these results demonstrate how interactions between cAMP and calcium pathways at the level of the InsP(3)R modulate hepatic glucose production under fasting conditions and in diabetes.

Citing Articles

Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells.

Sun L, Cui Z, Feng Q, Muhammad J, Jin Y, Zhao S Front Pharmacol. 2025; 16:1540567.

PMID: 40070568 PMC: 11893604. DOI: 10.3389/fphar.2025.1540567.

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases.

Rubinelli L, Manzo O, Sungho J, Del Gaudio I, Bareja R, Marino A Nat Commun. 2025; 16(1):1968.

PMID: 40000621 PMC: 11862206. DOI: 10.1038/s41467-025-56869-9.

Mulberry leaf ameliorate STZ induced diabetic rat by regulating hepatic glycometabolism and fatty acid β-oxidation.

Lv B, Liu S, Li Y, Li Z, An Y, He C Front Pharmacol. 2024; 15:1428604.

PMID: 39635431 PMC: 11614592. DOI: 10.3389/fphar.2024.1428604.

Activation of estrogen-related receptor γ by calcium and cadmium.

Wang Q, Huang N, Psaltis J, Gahtani R, Yan G, Lu D Front Endocrinol (Lausanne). 2024; 15:1400022.

PMID: 39507056 PMC: 11537906. DOI: 10.3389/fendo.2024.1400022.

Purinergic signaling in liver disease: calcium signaling and induction of inflammation.

Ulrich H, Glaser T, Thomas A Purinergic Signal. 2024; .

PMID: 39320433 DOI: 10.1007/s11302-024-10044-9.

References

Hogan P, Chen L, Nardone J, Rao A . Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17(18):2205-32. DOI: 10.1101/gad.1102703. View

Wang Y, Vera L, Fischer W, Montminy M . The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature. 2009; 460(7254):534-7. PMC: 2730924. DOI: 10.1038/nature08111. View

Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S . A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature. 2008; 456(7219):269-73. PMC: 2597669. DOI: 10.1038/nature07349. View

Wang B, Moya N, Niessen S, Hoover H, Mihaylova M, Shaw R . A hormone-dependent module regulating energy balance. Cell. 2011; 145(4):596-606. PMC: 3129781. DOI: 10.1016/j.cell.2011.04.013. View

Yoon Y, Lee M, Ryu D, Kim J, Ma H, Seo W . Suppressor of MEK null (SMEK)/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis. Proc Natl Acad Sci U S A. 2010; 107(41):17704-9. PMC: 2955085. DOI: 10.1073/pnas.1012665107. View

Patterson R, Boehning D, Snyder S . Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem. 2004; 73:437-65. DOI: 10.1146/annurev.biochem.73.071403.161303. View

Yoon J, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J . Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001; 413(6852):131-8. DOI: 10.1038/35093050. View

Herzig S, Long F, Jhala U, Hedrick S, Quinn R, Bauer A . CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 2001; 413(6852):179-83. DOI: 10.1038/35093131. View

Jansson D, Ng A, Fu A, Depatie C, Al Azzabi M, Screaton R . Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc Natl Acad Sci U S A. 2008; 105(29):10161-6. PMC: 2481316. DOI: 10.1073/pnas.0800796105. View

10.

Wu Z, Huang X, Feng Y, Handschin C, Feng Y, Gullicksen P . Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells. Proc Natl Acad Sci U S A. 2006; 103(39):14379-84. PMC: 1569674. DOI: 10.1073/pnas.0606714103. View

11.

Futatsugi A, Nakamura T, Yamada M, Ebisui E, Nakamura K, Uchida K . IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science. 2005; 309(5744):2232-4. DOI: 10.1126/science.1114110. View

12.

Szado T, Vanderheyden V, Parys J, De Smedt H, Rietdorf K, Kotelevets L . Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci U S A. 2008; 105(7):2427-32. PMC: 2268153. DOI: 10.1073/pnas.0711324105. View

13.

Volpe P . Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release. II. Effect of cAMP-dependent protein kinase. Am J Physiol. 1990; 258(6 Pt 1):C1086-91. DOI: 10.1152/ajpcell.1990.258.6.C1086. View

14.

Screaton R, Conkright M, Katoh Y, Best J, Canettieri G, Jeffries S . The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 2004; 119(1):61-74. DOI: 10.1016/j.cell.2004.09.015. View

15.

Wakelam M, Murphy G, Hruby V, Houslay M . Activation of two signal-transduction systems in hepatocytes by glucagon. Nature. 1986; 323(6083):68-71. DOI: 10.1038/323068a0. View

16.

Altarejos J, Montminy M . CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol. 2011; 12(3):141-51. PMC: 4324555. DOI: 10.1038/nrm3072. View

17.

Bird G, Burgess G, Putney Jr J . Sulfhydryl reagents and cAMP-dependent kinase increase the sensitivity of the inositol 1,4,5-trisphosphate receptor in hepatocytes. J Biol Chem. 1993; 268(24):17917-23. View

18.

Cruz L, Guerra M, Kruglov E, Mennone A, Garcia C, Chen J . Regulation of multidrug resistance-associated protein 2 by calcium signaling in mouse liver. Hepatology. 2010; 52(1):327-37. PMC: 3025771. DOI: 10.1002/hep.23625. View

19.

Dentin R, Liu Y, Koo S, Hedrick S, Vargas T, Heredia J . Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature. 2007; 449(7160):366-9. DOI: 10.1038/nature06128. View

20.

Ferris C, Huganir R, Bredt D, Cameron A, Snyder S . Inositol trisphosphate receptor: phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles. Proc Natl Acad Sci U S A. 1991; 88(6):2232-5. PMC: 51204. DOI: 10.1073/pnas.88.6.2232. View